110 related articles for article (PubMed ID: 35168526)
1. Bismuth Lipophilic Nanoparticles (BisBAL NP) Inhibit the Growth of Tumor Cells in a Mouse Melanoma Model.
García-Cuellar CM; Cabral-Romero C; Hernández-Delgadillo R; Solis-Soto JM; Meester I; Sánchez-Pérez Y; Nakagoshi-Cepeda SE; Pineda-Aguilar N; Sánchez-Nájera RI; Nakagoshi-Cepeda MAA; Chellam S
Anticancer Agents Med Chem; 2022; 22(14):2548-2557. PubMed ID: 35168526
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells.
Hernandez-Delgadillo R; García-Cuéllar CM; Sánchez-Pérez Y; Pineda-Aguilar N; Martínez-Martínez MA; Rangel-Padilla EE; Nakagoshi-Cepeda SE; Solís-Soto JM; Sánchez-Nájera RI; Nakagoshi-Cepeda MAA; Chellam S; Cabral-Romero C
Int J Nanomedicine; 2018; 13():6089-6097. PubMed ID: 30323596
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial and antitumor activities of an alginate-based membrane loaded with bismuth nanoparticles and cetylpyridinium chloride.
Cabral-Romero C; Hernández-Delgadillo R; Nakagoshi-Cepeda SE; Sánchez-Najéra RI; Escamilla-García E; Solís-Soto JM; García-Cuellar CM; Sánchez-Pérez Y; Flores-Treviño SM; Pineda-Aguilar N; Cauich-Rodríguez JV; Meester I; Chellam S
J Appl Biomater Funct Mater; 2024; 22():22808000241236590. PubMed ID: 38444166
[TBL] [Abstract][Full Text] [Related]
4. Cumulative antitumor effect of bismuth lipophilic nanoparticles and cetylpyridinium chloride in inhibiting the growth of lung cancer.
García-Cuellar CM; Hernández-Delgadillo R; Torres-Betancourt JA; Solis-Soto JM; Meester I; Sánchez-Pérez Y; Pineda-Aguilar N; Nakagoshi-Cepeda SE; Sánchez-Nájera RI; Nakagoshi-Cepeda MAA; Chellam S; Cabral-Romero C
J Appl Biomater Funct Mater; 2023; 21():22808000231161177. PubMed ID: 36942951
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic Effect of Lipophilic Bismuth Dimercaptopropanol Nanoparticles on Epithelial Cells.
Rene HD; Badireddy AR; José MS; Francisco CC; Israel MG; Isela SN; Chellam S; Claudio CR
J Nanosci Nanotechnol; 2016 Jan; 16(1):203-9. PubMed ID: 27398446
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial potential of AH Plus supplemented with bismuth lipophilic nanoparticles on
Torres-Betancourt JA; Hernandez-Delgadillo R; Flores-Treviño JJ; Solís-Soto JM; Pineda-Aguilar N; Nakagoshi-Cepeda MAA; Isela Sánchez-Nájera R; Chellam S; Cabral-Romero C
J Appl Biomater Funct Mater; 2022; 20():22808000211069221. PubMed ID: 35114826
[TBL] [Abstract][Full Text] [Related]
7. Surface antigen exposure by bismuth dimercaprol suppression of Klebsiella pneumoniae capsular polysaccharide.
Domenico P; Tomas JM; Merino S; Rubires X; Cunha BA
Infect Immun; 1999 Feb; 67(2):664-9. PubMed ID: 9916074
[TBL] [Abstract][Full Text] [Related]
8. Bismuth dimercaptopropanol (BisBAL) inhibits formation of multispecies wastewater flocs.
Badireddy AR; Chellam S
J Appl Microbiol; 2011 Jun; 110(6):1426-37. PubMed ID: 21410850
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial potential of bismuth lipophilic nanoparticles embedded into chitosan-based membrane.
Martínez-Martínez MA; Hernandez-Delgadillo R; Abada BS; Pineda-Aguilar N; Solís-Soto JM; Nakagoshi-Cepeda MAA; Nakagoshi-Cepeda SE; Chellam S; Sánchez-Nájera RI; Cabral-Romero C
Dent Mater J; 2019 Jul; 38(4):611-620. PubMed ID: 31105160
[TBL] [Abstract][Full Text] [Related]
10. Reduction of polysaccharide production in Pseudomonas aeruginosa biofilms by bismuth dimercaprol (BisBAL) treatment.
Huang CT; Stewart PS
J Antimicrob Chemother; 1999 Nov; 44(5):601-5. PubMed ID: 10552975
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial and antibiofilm activities of MTA supplemented with bismuth lipophilic nanoparticles.
Hernandez-Delgadillo R; Del Angel-Mosqueda C; Solís-Soto JM; Munguia-Moreno S; Pineda-Aguilar N; Sánchez-Nájera RI; Chellam S; Cabral-Romero C
Dent Mater J; 2017 Jul; 36(4):503-510. PubMed ID: 28420830
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cells.
Cabral-Romero C; Solís-Soto JM; Sánchez-Pérez Y; Pineda-Aguilar N; Meester I; Pérez-Carrillo E; Nakagoshi-Cepeda SE; Sánchez-Nájera RI; Nakagoshi-Cepeda MAA; Hernandez-Delgadillo R; Chellam S; García-Cuéllar CM
Anticancer Drugs; 2020 Mar; 31(3):251-259. PubMed ID: 31764012
[TBL] [Abstract][Full Text] [Related]
13. Bismuth dimercaptopropanol (BisBAL) inhibits the expression of extracellular polysaccharides and proteins by Brevundimonas diminuta: implications for membrane microfiltration.
Badireddy AR; Chellam S; Yanina S; Gassman P; Rosso KM
Biotechnol Bioeng; 2008 Feb; 99(3):634-43. PubMed ID: 17705249
[TBL] [Abstract][Full Text] [Related]
14. Assessment of bismuth thiols and conventional disinfectants on drinking water biofilms.
Codony F; Domenico P; Mas J
J Appl Microbiol; 2003; 95(2):288-93. PubMed ID: 12859760
[TBL] [Abstract][Full Text] [Related]
15. Improvement of anti-biofouling properties of hollow fiber membranes with bismuth-BAL chelates (BisBAL).
Yavuz FNS; Sengur Tasdemir R; Turken T; Urper GM; Koyuncu I
Environ Technol; 2019 Jan; 40(1):19-28. PubMed ID: 28880121
[TBL] [Abstract][Full Text] [Related]
16. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.
Yu KF; Zhang WQ; Luo LM; Song P; Li D; Du R; Ren W; Huang D; Lu WL; Zhang X; Zhang Q
Int J Nanomedicine; 2013; 8():2473-85. PubMed ID: 23885174
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.
Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N
Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of bismuth antibacterial activity with lipophilic thiol chelators.
Domenico P; Salo RJ; Novick SG; Schoch PE; Van Horn K; Cunha BA
Antimicrob Agents Chemother; 1997 Aug; 41(8):1697-703. PubMed ID: 9257744
[TBL] [Abstract][Full Text] [Related]
19. Long-term MBR performance of polymeric membrane modified with Bismuth-BAL chelate (BisBAL).
Turken T; Kose-Mutlu B; Okatan S; Durmaz G; Guclu MC; Guclu S; Ovez S; Koyuncu I
Environ Technol; 2019 Jun; 40(15):2011-2017. PubMed ID: 29409397
[TBL] [Abstract][Full Text] [Related]
20. Optimization and in-vitro/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model.
Yoncheva K; Merino M; Shenol A; Daskalov NT; Petkov PS; Vayssilov GN; Garrido MJ
Int J Pharm; 2019 Feb; 556():1-8. PubMed ID: 30529664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
